Business Context and Reporting Period
This Form 6-K filing by Innate Pharma S.A. covers the month of September 2022, with a report date of September 23, 2022. The registrant is a foreign private issuer based in Marseille, France, and files annual reports on Form 20-F. The filing incorporates by reference a press release dated September 23, 2022 (Exhibit 99.1) into the company's registration statement on Form F-3.
Key Financial Metrics
The provided filing text does not contain specific financial data. No values are disclosed for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, specific risks, contingencies, or unusual items. The document serves primarily as a cover sheet to incorporate the referenced press release by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated September 23, 2022) for the actual content and announcements referenced in this filing.
- Verify the status of the Form F-3 registration statement (File No. 333-252074) to understand the context of the incorporation by reference.
- Consult the most recent Form 20-F or quarterly reports for detailed financial metrics, as this Form 6-K does not contain them.